Updated: 10/4/2016

Chemotherapy

Topic
Review Topic
0
0
Questions
5
0
0
Evidence
5
0
0
Videos
4
Introduction
  • Mechanism
    • induces apoptosis  
    • may target specific proteins over-expressed in cancer cells
      • e.g. tyrosine kinase inhibitors 
        • imatinib (Gleevec) for chronic myelogenous leukemia
        • gefitinib (EGFR inhibitor, Iressa) for lung, breast cancer
        • erlotinib (EGFR inhibitor, Tarceva) for NSCLC and pancreatic cancer
    • eliminates micrometastasis in lungs
    • >98% necrosis with chemotherapy is good prognostic sign
  • Resistance
    • expression of multi-drug resistance (MDR) gene portends very poor prognosis
      • cells can pump chemotherapy out of cell
      • present in 25% of primary lesions and 50% of metastatic lesions
Indications
  • Integral component of treatment along with surgical resection in
    • osteosarcoma (intramedullary and periosteal)
    • Ewing's sarcoma/primative neuroectodermal tumor
    • malignant fibrous histiocytoma
    • dedifferentiated chondrosarcoma
    • chemotherapy for soft tissue sarcoma is controversial 
Administration
  • Preoperative chemotherapy given for 8-12 weeks
  • Maintenance chemotherapy for 6-12 months
Specific Agents & Antidotes
  • Doxorubicin (Adriamycin)
    • mechanism
      • doxorubicin is an anthracycline antibiotic commonly used in oncological protocols
      • functions as a cytostatic agent
    • side effects
      • cardiac toxicity  
        • leads to congestive heart failure
        • dexrazoxane used to mitigate toxicity
  • Agents and Antidotes  
    • mechlorethamine/cisplatin - give sodium thiosulfate
    • doxorubicin/epirubicin - give dexrazoxane
    • vinca alkaloids (vincristine/vinblastine) - give hot compress and hyaluronidase
      • give cold compress for all other vesicants
 
 

Please rate topic.

Average 2.9 of 38 Ratings

Thank you for rating! Please vote below and help us build the most advanced adaptive learning platform in medicine

The complexity of this topic is appropriate for?
How important is this topic for board examinations?
How important is this topic for clinical practice?
Questions (5)

(OBQ09.167) Tyrosine kinase inhibitors are currently used in the medical treatment of which of the following? Review Topic

QID: 2980
1

Paget's disease

15%

(311/2106)

2

Osteogenesis imperfecta

4%

(78/2106)

3

Cancer

70%

(1473/2106)

4

Osteoporosis

3%

(69/2106)

5

Osteopetrosis

8%

(171/2106)

ML 3

Select Answer to see Preferred Response

PREFERRED RESPONSE 3

(OBQ11.175) Doxorubicin, a common chemotherapeutic agent used in the treatment of osteosarcoma, has which of the following major dose-limiting toxicities? Review Topic

QID: 3598
1

Cardiomyopathy

90%

(1907/2122)

2

Pulmonary fibrosis

5%

(107/2122)

3

Myelosuppression

3%

(70/2122)

4

Encephalopathy

0%

(7/2122)

5

Urotoxicity

1%

(26/2122)

ML 1

Select Answer to see Preferred Response

PREFERRED RESPONSE 1

(OBQ05.101) Which of the following is true regarding apoptosis? Review Topic

QID: 987
1

It is the primary mechanism by which conventional chemotherapy kills cancer cells

79%

(687/868)

2

It is the primary mechanism by which cancer metastasis occurs

1%

(12/868)

3

It is the primary mechanism by which cancer causes organ failure

1%

(10/868)

4

It is the primary mechanism by which cancer forms lytic lesions in bone

3%

(22/868)

5

None of the above

16%

(137/868)

ML 2

Select Answer to see Preferred Response

PREFERRED RESPONSE 1

(OBQ06.125) Pharmacologically induced apoptosis occurs during the medical therapy of which of the following disorders? Review Topic

QID: 311
1

Phenol adjuvant resection bed therapy in giant cell tumors

11%

(173/1511)

2

TNF-alpha inhibitor treatment in rheumatoid arthritis

5%

(82/1511)

3

Colchicine treatment for gout

2%

(35/1511)

4

Vancomycin therapy for MRSA infection

2%

(31/1511)

5

Doxorubicin neoadjuvant chemotherapy for cancer

78%

(1186/1511)

ML 2

Select Answer to see Preferred Response

PREFERRED RESPONSE 5

(OBQ08.273) What is the major side-effect of doxorubicin? Review Topic

QID: 659
1

neuropathy

5%

(93/1993)

2

hearing loss

3%

(58/1993)

3

pulmonary fibrosis

5%

(93/1993)

4

cardiac toxicity

86%

(1721/1993)

5

liver cirrhosis

1%

(20/1993)

ML 1

Select Answer to see Preferred Response

PREFERRED RESPONSE 4
ARTICLES (9)
POSTS (1)
VIDEOS (4)
Topic COMMENTS (2)
Private Note